微RNA-34a调解了阿尔多斯特诱导的内皮衰老加速
Minyue Jia1, Liya Lin2, Boyun Yang3
1Department of Ultrasonography, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
International journal of hypertension
|April 14, 2025
概括
微RNAs (miRs) 调解阿尔多斯对血管细胞的有害影响. 具体来说,miR-34a通过抑制NOTCH1促进内皮细胞衰老,为血管疾病提供了潜在的治疗点.
科学领域:
- 内分泌学 在内分泌学.
- 分子生物学分子生物学
- 血管生物学 血管生物学
背景情况:
- 不适当的阿尔多素生产有助于动脉高血压和血管损伤.
- 内皮功能障碍是与阿尔多斯激素相关的血管改造的关键因素.
- 微RNAs (miRs) 在阿尔多斯特诱导的内皮功能障碍中的作用需要进一步研究.
研究的目的:
- 研究微RNAs (miRs) 作为阿尔多素对内皮功能障碍影响的调解者的作用.
- 为了确定参与阿尔多素诱导的内皮细胞衰老的特定miRs.
- 阐明阿尔多素通过哪种分子途径影响内皮细胞.
主要方法:
- 人类静脉内皮细胞 (HUVEC) 被用作模型系统.
- 对HUVECs进行了阿尔多斯特治疗,以评估其对细胞增殖,迁移和衰老的影响.
- 进行了定量实时PCR和西部斑分析,以测量miR-34a和NOTCH1的表达.
- 使用特定的miR-34a抑制剂来评估功能意义.
主要成果:
- 阿尔多斯特治疗抑制了HUVEC的增殖和迁移,同时促进了衰老.
- 阿尔多素暴露显著上调了HUVECs中的miR-34a表达.
- 抑制miR-34a可以逆转阿尔多的抗增殖和前效应.
- 发现miR-34a对NOTCH1产生负面调节,NOTCH1是Notch信号通路的关键组成部分.
结论:
- miR-34a是阿尔多斯激素诱导的内皮细胞衰老的关键媒介.
- miR-34a/NOTCH1轴在与阿尔多素相关的内皮功能障碍中发挥着重要作用.
- 向miR-34a为阿尔多素诱导的血管疾病提供了潜在的治疗策略.
相关概念视频
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
321
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
321
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
394
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
394
01:30Antihypertensive Drugs: Angiotensin II Receptor Blockers
544
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
544
01:33Hormonal Regulation
32.7K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
32.7K